Trophoblasts, the structural cells of the placenta, are thought to play a determinant role in in utero HIV type 1 (HIV-1) transmission. We have accumulated evidence suggesting that HIV-1 infection of these cells is associated with uptake by an unusual clathrin/caveolae-independent endocytic pathway and that endocytosis is followed by trafficking through multiple organelles. Furthermore, part of this trafficking involves the transit of HIV-1 from transferrin-negative to EEA1 and transferrin-positive endosomes, suggesting a merger from nonclassical to classical endocytic pathways in these cells. In the present article, the relationship between the presence of HIV-1 within specific endosomes and infection was studied. We demonstrate that viral infection is virtually lost when endosome inhibitors are added shortly after exposure to HIV-1. Thus, contrary to what is seen in CD4 ؉ T lymphocytes, the initial presence of HIV-1 within the endosomes is mandatory for infection to take place. Importantly, this process is independent of the viral envelope proteins gp120 and gp41. The Rab family of small GTPases coordinates the vesicular transport between the different endocytic organelles. Experiments performed with various expression vectors indicated that HIV-1 infection in polarized trophoblasts relies on Rab5 and Rab7 without the contribution of Arf6 or Rab11. Furthermore, we conclude that Rab5 drives movements from raft-rich region to early endosomes, and this transit is required for subsequently reaching late endosomes via Rab7. This complex trafficking is mandatory for HIV-1 infection to proceed in human polarized trophoblasts.
V ertical transmission of the HIV type 1 (HIV-1) 3 is a serious global health problem. Currently, 2.1 millions children Ͻ 15 years of age are infected by HIV-1 worldwide and 90% of these infections are associated with mother-to-child transmission (MTCT) of this retrovirus (1) . The risk of vertical transmission lies within the range of 15-25% in industrialized countries and reaches 35% in developing countries (1) . MTCT may occur in utero, at birth during delivery, or through breastfeeding (reviewed in Ref. 2) . Vertical transmission occurring through breastfeeding or at birth most likely involves ingestion of contaminated fluids (e.g., milk, vaginal secretion, and blood) by the infant. In contrast, in utero HIV-1 transmission requires a direct implication of the placenta (reviewed in Ref. 2) .
Mathematical modeling has estimated that while 65% of the infections occur at birth, one-third of the infants are considered to become infected in utero Ͻ2 mo before delivery (3) . This being said, in utero HIV-1 transmission has been documented by several groups (4 -7) . In addition, vertical transmission can occur early during pregnancy because HIV-1 has been detected in aborted fetuses as early as after 8 wk of gestation (8) and in first and second trimester fetuses (9 -12) . In utero transmission of HIV-1 is poorly understood, and the importance of studying such a process is related to the following facts. If we consider again the mathematical modeling cited above, it can be estimated that among the 2 million children currently living with HIV-1/AIDS, hundreds of thousands of these infections occurred in utero. Hence, although in utero transmission is unlikely the primary cause of infection in infants, given the scale of the pandemic the resulting numbers are substantial. Additionally, the risks of acquiring HIV-1 is 1.3-fold higher in adult African women than in men of the same age, and among young women aged between 15 and 24 years, this disparity is more important because a 3-fold difference is reported. As a result, women are becoming infected at a higher frequency than men (13, 14) . Antiretroviral therapies are known to significantly reduce the incidence of vertical transmission (15) . However, according to recent statistics gathered in developing countries, only 10% of pregnant women received prebirth counseling for preventing MTCT and only 7% of people had access to antiretroviral treatments in 2003 (13, 14) . Consequently, initiatives to prevent vertical transmission of HIV-1 are now aimed at developing strategies that are readily available to women. In this context, it is well recognized that a better understanding of how and when vertical transmission occurs is crucial (13, 14) .
The placenta functions as a barrier composed of a double layer of polarized epithelial-type cells, i.e., the cytotrophoblasts and syncytiotrophoblasts. Trophoblasts separate the maternal and fetal blood circulations and control fluxes between them. Thus, HIV-1 must first cross this natural barrier before reaching the fetal circulation. Current models propose that following infection of trophoblasts and/or transcytosis across these cells, HIV-1 is released from the basolateral pole of the trophoblasts (facing the fetal circulation) leading to productive infection of the underlying fetal cells (16 -23) . The mechanisms associated with these events are ill-defined, and it is also unknown in which proportions each pathway contributes to vertical transmission.
HIV-1 is an enveloped virus that gains entry into susceptible cells upon fusion of its outer membrane with the plasma membrane of a target cell. This process involves coordinated interactions between the viral envelope (Env) glycoproteins gp120 and gp41 and the primary cellular receptor CD4 and a coreceptor such as CXCR4 or CCR5. HIV-1 infection is pH independent and does not require endocytosis of CD4 (24, 25) . Several reports have documented that trophoblasts sustain HIV-1 infection both in vitro and in vivo (16, 17, 19 -23, 26, 27) . However, as with other epithelial cells, macrophages, dendritic cells, and astrocytes, their permissiveness to HIV-1 infection is estimated to be lower than that of CD4 ϩ T lymphocytes, the primary target of HIV-1 infection (our unpublished observations and Ref. 27 ). One of the reasons postulated for such a restricted susceptibility to virus infection is linked with the low to absent expression of CD4, CXCR4, and CCR5 in trophoblasts (28 -32) . At the same time, the process of viral entry is enigmatic given the absence of the appropriate receptor and coreceptors in these cells in spite of a moderate productive infection. Contrary to previous assumptions, we made the surprising discovery that HIV-1 is massively endocytosed within trophoblastic cells (27, 33) . However, as a consequence, virions are predominantly trapped within the endosomal compartments of the cells. This event is believed to translate into weak HIV-1 production due to an inefficient endosomal escape by HIV-1 combined to a rapid degradation of the majority of the viral particles in the endosomal/ lysosomal compartments of the infected cells. Because of this entry pathway, although trophoblasts display no blocking mechanism for viral transcription or viral production, proinflammatory cytokines are required to promote virus gene expression in these cells. It is postulated that such cytokines, transiently expressed during pregnancy, sporadically create favorable conditions leading to in vivo vertical transmission of this retrovirus (21, 27, 31) . It is important to state that virus entry leading to infection of trophoblasts is unexpectedly independent of gp120 and gp41 (G. Vidricaire and M. J. Tremblay, submitted for publication). Finally, inhibitors of the function of the endosomes block HIV-1 infection of trophoblasts (33) . This last observation is particularly meaningful because it implies that internalization of HIV-1 by endocytosis, which results in the presence of viral material within the endosomes, is an obligatory step for infection to proceed in human trophoblasts. This is radically different from what is seen in CD4 ϩ T lymphocytes (24, 25, 34) . Given that internalization of HIV-1 within trophoblasts is required for infection to take place in these cells, defining how the presence of HIV-1 within the endocytic compartments relates to infection in trophoblastic cells is crucial. This article addresses this key question.
Upon internalization, macromolecules (or pathogens) travel through a number of endocytic subcompartments where sorting decisions are made for recycling to the plasma membrane or targeting to the lumen of late endosomes/lysosomes. Hence, the fate of macromolecules/pathogens is dictated by their intracellular endocytic route. Importantly, the precise location in endocytic compartments where viral escape is occurring is often critical in yielding productive infection or not (35) . The Rab family of small GTPases coordinates the vesicular transport between the different endocytic organelles. Distinct Rab proteins have been identified and each is specifically associated with a particular organelle or pathway. For instance, Rab5 is needed for early endosomes, Rab7 for transport from early to late endosomes, and from late endosomes to lysosomes, whereas Rab11 is enriched in recycling endosomes (36) .
Dominant-negative or active mutant versions of Rab proteins have proven to be powerful tools for analyzing defined trafficking pathways within cells (reviewed in Ref. 37 ). The dominant-negative Rab5 mutant (Rab5 S34N), defective in guanine-nucleotide binding, inhibits early endosome fusion and causes the accumulation of small vesicles at the cell periphery. By contrast, the constitutively active Rab5 mutant (Rab5 Q79L) enhances endocytosis and early endosome fusion, causing the formation of enlarged early endosomes. Similar observations are obtained upon overexpression of wild-type Rab5 (38) . The dominant-negative Rab7 mutant (Rab7 T22N) blocks the transport of receptors to late endosomes and results in its retention in Rab5-positive early endosomes. Cells expressing a wild-type or a constitutively active Rab7 mutant (Rab7 Q67L) exhibit enhanced association with lysosomes (39, 40) . The Rab11 mutant defective in GTP binding (Rab11 S25N) impairs recycling by inhibiting transport from sorting endosomes (early endosomes) to the recycling endosomes (41) . Overexpression of wild-type Rab11 or dominant-active Rab11 (Rab11 Q70L) promotes recycling in some instances (42) .
An important issue arises for macromolecules/pathogens internalized independently of clathrin-coated pits. Indeed, these macromolecules may or may not intersect with the classical endocytic pathway, and if indeed they do, the mechanism underlying such an event is poorly understood. The Ras-related protein Arf6 can return glycosylphosphatidylinositol-anchored proteins to the plasma membrane. Alternatively, inactivation of Arf6 leads to convergence with the classical early endosomes and traffic to late endosomes/lysosomes (43) .
As described earlier, the contact between HIV-1 and trophoblasts results in massive and rapid uptake of virions within these cells by endocytosis, a process that is required for infection to proceed in trophoblasts (27, 33) . We have recently provided evidence that the internalization pathway leading to HIV-1 infection of trophoblasts is independent of clathrin-coated pits and caveolae but is sensitive to raft-perturbing drugs (G. Vidricaire and M. J. Tremblay, submitted for publication). Moreover, the early events associated with HIV-1 infection in polarized human trophoblasts involve an active participation of the endocytic machinery (33) . For instance, confocal studies demonstrated that although HIV-1 particles do not initially colocalize with transferrin in polarized JAR cells, a marker of the classical endocytic pathway, they do at later time points (G. Vidricaire and M. J. Tremblay, submitted for publication). Moreover, we found that HIV-1 is in part associated with EEA1-expressing early endosomes (33) . Given that HIV-1 internalization does not rely on clathrin-mediated endocytosis, the taken intracellular endocytic route most likely involves a merger between nonclassical endocytic and classical pathways (G. Vidricaire and M. J. Tremblay, submitted for publication). In contrast, with time, some virions also reach Rab11 ϩ recycling endosomes. However, the majority of the virions accumulate within CD63 ϩ late endosomes (33) . Given that HIV-1 is located within different organelles upon internalization into trophoblasts and its presence within endosomes is necessary for infection to ensue (33) , defining which organelle(s) is required for infection to proceed in polarized trophoblasts might provide critical information on in utero HIV-1 transfer. In this study, the involvement of specific Rab proteins (i.e., Rab5, Rab7, and Rab11) and Arf6 was analyzed in the context of viral infection in polarized trophoblasts. We found an intriguing relationship between trafficking of HIV-1 within the endocytic compartments and viral infection. Collectively, our data provide unprecedented information on the identity of subcellular organelles that might be involved in vertical transmission of HIV-1.
Materials and Methods

Cells
The human trophoblastic JAR and 293T cell lines were obtained from the American Type Culture Collection. Cells were maintained as previously described (33) . For the experiments performed in this work, JAR cells were grown into a polarized monolayer. This goal was achieved by seeding JAR cells in 24-well cell culture inserts containing a 0.4-m pore size polyethylene terephthalate track-etched membrane (BD Biosciences Labware), and the cells were grown to complete confluence and polarize for 4 days as described previously (33) .
Molecular constructs and preparation of virus stocks
The pNL4-3 (X4-tropic) (herein referred as to NL4-3 wild type) is a fulllength infectious molecular clone of HIV-1. The NL4-3 Luc ϩ E Ϫ R ϩ vector was constructed by inserting a frameshift mutation near the env gene and the firefly luciferase-reported gene into the nef gene (supplied by N. R. Landau, The Salk Institute for Biological Studies, La Jolla, CA) (44) . pHXB2-env is a mammalian expression vector coding for the HIV-1 HXB2 (X4-tropic) Env glycoprotein. This construct was obtained through the AIDS Repository and Reagent Program. The pcDNA-1/Amp-based expression vector coding for the HIV-1 Ada-M (R5-tropic) full-length Env protein was generously provided by N. R. Landau. The pHCMV-G molecular construct codes for the broad-host-range vesicular stomatitis virus Env glycoprotein G (VSV-G) under the control of the human CMV promoter (45) . Viruses were produced by calcium phosphate transfection of 293T cells as described previously (27) . Using the same protocol, the NL4-3 Luc ϩ E Ϫ R ϩ expression vector was used to produce Env-deficient reporter viruses (called NL4-3⌬Env).
Transfection of polarized JAR cells
The cDNAs of the small GTPase proteins and their mutants are all fusion proteins with the enhanced GFP (EGFP). The EGFP, EGFP-Rab5 (i.e., Rab5 WT, Rab5 S34N, and Rab5 Q79L) and EGFP-Rab11 expression vectors (i.e., Rab11 WT, Rab11 S25N, and Rab11 Q70L) were provided by S. S. Ferguson (Robarts Research Institute, London, Ontario, Canada). The EGFP-Rab7 expression vectors (i.e., Rab7 Q67L and Rab7 T22N) were supplied by B. van Deurs (The Panum Institute, University of Copenhagen, Copenhagen, Denmark), and the EGFP-Arf6 expression vectors (i.e., Arf6 WT, Arf6 T27N and Arf6 Q67L) were gifts from J. G. Donaldson (National Institutes of Health, Bethesda, MD). Polarized JAR cells (as described above) were transfected using Lipofectamine (Invitrogen Canada). Cells were either mock-transfected or transfected with 0.2 g of carrier DNA and 5, 6, 15, or 25 ng of the expression vector of interest. The following day, cells were washed three times with PBS. Viral entry and infection assays were performed 12-24 h later as described below. Transfection efficiencies when using the various Rab expression vectors reached 50% as monitored by EGFP expression (data not shown).
Virus entry assay
Polarized JAR cells were pretreated with vehicle, 0.1 M bafilomycin A1, 10 mM ammonium chloride (NH 4 Cl), or 10 nM wortmannin (Sigma-Aldrich) for 30 min at 37°C. These pretreated cells or the transiently transfected JAR cells were exposed to pseudotyped and Env-deficient viruses (250 ng of p24) for 1 h at 37°C. At this point, the cells were acid-treated (0.5 M NaCl and 1% acetic acid) at 4°C for 1 min and washed three times with ice-cold PBS to remove all uninternalized viral particles. Finally, the cells were lysed in ice-cold lysis buffer (20 mM HEPES (pH 7.4), 150 mM NaCl, and 0.5% Triton X-100), and virus content was measured using a homemade p24 enzymatic test (46) .
Infection assay
Polarized JAR or Jurkat cells (1 ϫ 10 6 cells) were exposed to recombinant luciferase-encoding viruses pseudotyped with HXB-2 (0, 100, 125, and 250 ng of p24 or 250 ng together with 10 M zidovudine (AZT)) at 37°C for 24 h. In some experiments, untransfected or transiently transfected polarized JAR cells were exposed to pseudotyped viruses (Ada-M or HXB-2) (250 ng of p24), Env-deficient viruses (250 ng of p24), or VSV-G pseudotypes (0.2 ng of p24) at 37°C for 24 h. At this time point, TNF-␣ (10 ng/ml) (PeproTech) was added for 24 h at 37°C to induce virus gene expression (27) . Finally, the cells were lysed, and luciferase activity was monitored in each cell lysate as described previously (47) . For experiment aimed at blocking virus infection, the cells were pretreated for 30 min at 37°C with vehicle (used as a control), 0.1 M bafilomycin A1, 10 mM NH 4 Cl, or 1 mg/ml leupeptin (Sigma-Aldrich Canada). In these assays, the drugs were present throughout the duration of the experiment. For esti-mating kinetics of inhibition of HIV-1 infection, bafilomycin A1 or NH 4 Cl was added 30 min before virus exposure for 6 h at 37°C. Cells were next washed twice with PBS, and fresh medium was added. Bafilomycin A1 or NH 4 Cl was added at this point (i.e., 6 h after the onset of infection) or 12 or 24 h following the onset of virus infection. The proinflammatory cytokine TNF-␣ (10 ng/ml) was also added at 6 h following the initial exposure to HIV-1. Finally, the cells were lysed 24 h later, and luciferase activity, which is indicative of virus gene expression, was monitored in each cell lysate.
Cell fractionation assay
Polarized JAR cells were pretreated with vehicle, 0.1 M bafilomycin A1, 10 mM NH 4 Cl, or 10 nM wortmannin for 30 min at 37°C. The cells were then exposed to viruses pseudotyped with VSV-G, Ada-M, or HXB-2 Env (250 ng of p24) for 4 h (for 30 min and 2 h in some experiments) at 37°C. At this point, the cells were washed three times with PBS and trypsinized for 5 min at 37°C. The cells were pelleted by centrifugation (1200 rpm for 5 min at 4°C) and washed twice with ice-cold PBS. To disrupt cellular membranes, cells were resuspended in 600 l of ice-cold hypotonic buffer (10 mM Tris-HCl (pH 7.5), 10 mM KCl, and 1 mM EDTA) for 1 min and broken down by Dounce homogenization (three strokes, 7-ml B pestles). Nuclei, cell debris, and undamaged cells were pelleted by centrifugation (1800 rpm for 5 min at 4°C). Supernatants containing cytosol and vesicles (including endosomes) were centrifuged at 12,000 rpm for 90 min at 4°C in a Heraeus centrifuge. Supernatant that represents the cytosolic fraction was adjusted to 0.5% Triton X-100, while the pellet, which is the vesicular fraction, was resuspended in lysis buffer (20 mM HEPES (pH 7.4), 150 mM NaCl, and 0.5% Triton X-100). The level of p24 present in each fraction was assessed using the p24 test.
Real-time PCR
Polarized JAR and Jurkat cells (1 ϫ 10 6 cells) were either left untouched or exposed to NL4-3 wild-type viruses (250 ng of p24) in the absence or in the presence of AZT (10 M) for 48 h at 37°C. Infected cells were then washed twice with PBS and trypsinized at 37°C for 5 min. The cells were pelleted down by centrifugation (1200 rpm for 5 min at 4°C) and washed twice with PBS. Total cellular DNA was isolated using the DNeasy Tissue kit as described by the manufacturer (Qiagen). To quantify the amount of integrated viral DNA, we used the real-time PCR approach described by Suzuki et al. (48) . Briefly, a first round of PCR amplification was conducted using 100 ng of DNA and TaqDNA polymerase (Promega). The primers were as follows: Alu-specific sense primer (5Ј-TCC CAG CTA CTC GGG AGG CTG AGG-3Ј) and an antisense HIV-1-specific primer (M661) (5Ј-CCT GCG TCG AGA GAT CTC CTC TG-3Ј, 673-695). Cycling conditions included an initial denaturation step (94°C for 3 min), followed by 22 cycles of denaturation (94°C for 30s), annealing (66°C for 30s), and extension (70°C for 10 min) followed by a final extension (72°C for 10 min). The first PCR products were subsequently diluted 5-fold and subjected to a real-time PCR assay targeting the HIV-1 R/U5 region. The primers were as follows: R/U5 DNA sense primer (M667) (5Ј-GGC TAA CTA GGG AAC CCA CTG C-3Ј, 496 -517) and the antisense primer (AA55) (5Ј-CTG CTA GAG ATT TTC CAC ACT GAC-3Ј, 612-635). The fluorogenic probe HIV-FAM (Biosearch Technologies) was designed to anneal to the target between the sense primer M667 and the antisenseprimer AA55 in the R-U5 region: 5Ј-(FAM) TAG TGT GTG CCC GTC TGT TGT GTG AC (BHQ-1)-3Ј. PCR was performed using the Rotor-Gene 3000 four-channel multiplexing system (Corbett Research) and TaqDNA polymerase. Cycling conditions included 40 cycles of denaturation (95°C for 20 s) and extension (60°C for 1 min). To detect retrotranscribed viral DNA, isolated DNA was subjected to the first PCR in the absence of TaqDNA polymerase and then the samples were subjected to the real-time PCR.
Results
Trophoblastic cells are less susceptible to HIV-1 infection than T lymphocytes
Trophoblasts form in vivo a polarized-like epithelium. Cell polarity is essential to the biological properties and functions of simple epithelia because it leads to polarized endocytic pathways (apical and basolateral), each of which uses a complex succession of intracellular compartments that include the early, late, and recycling endosomes. These endocytic pathways control the fate of endocytosed macromolecules/pathogens. Hence, to study endocytic pathways in these cells, it is of utmost importance that cell polarity be maintained. Purification of primary trophoblasts is extremely difficult, but more importantly, it results in the loss of cell polarity (49) . To resolve this issue, the human trophoblastic cell line JAR, which exhibits many characteristics of the early placenta (50), was used. Indeed, when grown on permeable supports, they form a polarized epithelium-like monolayer closely resembling the trophoblastic barrier in vivo. This model system, which provides an elegant alternative to primary cells (33) , was used in this study.
To define the susceptibility to HIV-1 infection of polarized trophoblasts, comparative analyses were performed with a T lymphoid cell line (i.e., Jurkat) and unseparated PBMCs. First, polarized JAR cells were exposed to reporter viruses pseudotyped with HXB-2 Env (X4-tropic). Although a weak luciferase activity was detected following incubation with the two tested concentrations of viruses in the absence of TNF-␣, this activity was not due to true infection but was probably associated with the residual transfected DNA and/or free-secreted luciferase protein present in our viral stocks. Indeed, an inhibitor of reverse transcription, AZT, did not reduce these observed relative light unit (RLU) values ( Fig. 1A) . In contrast, luciferase activity could be readily detected in Jurkat cells in the absence of TNF-␣. Indeed, a 24-fold increase in reporter gene activity was seen when compared with mock-infected Jurkat cells ( Fig. 1B ). We have demonstrated in a previous publication that physiological concentrations of TNF-␣ are important for inducing HIV-1 long terminal repeat (LTR)-driven gene expression in trophoblasts (27) . Several cytokines, including TNF-␣, play pivotal roles during gestation and are mandatory for a successful pregnancy. It is postulated that the presence of TNF-␣ in our assays parallels in vivo situations by creating conditions that lead to higher HIV-1 expression and thus increased probabilities of vertical transmission of this retrovirus (27) . In agreement with this statement, when TNF-␣ was added to HXB-2-infected polarized JAR cells, we observed a marked induction in LTR-driven gene expression, reaching 28-and 46-fold increase following infection with 125 and 250 ng of p24, respectively ( Fig. 1A) . Importantly, AZT severely reduced this cytokine-induced LTR-driven gene expression, indicating that true infection had occurred in polarized JAR cells (Fig. 1A ). In these conditions, the induction triggered by TNF-␣ was more potent in Jurkat cells where a 159-fold increase in HIV-1 LTR-driven gene expression was detected ( Fig. 1B) .
Next, the presence of integrated viral DNA was assessed in polarized trophoblastic cells upon infection with wild-type NL4-3 viruses. JAR cells were either left untreated or exposed to wildtype NL4-3 viruses for 48 h, and total cellular DNA was isolated. To quantify the amount of integrated viral DNA, we used a pre-viously reported real-time PCR test, which provides a measure of true viral integration into the host cell chromatin. Indeed, this technical strategy uses primer sets designed to encompass both cellular and HIV-1-specific DNA sequences (48) . Briefly, a first round of PCR amplification was conducted using Alu-specific (Alu) and HIV-1-specific (M661) primers. This allows for amplification of a region that encompasses both cellular and HIV-1-specific DNA sequences and therefore amplifies only integrated viral DNA. The first PCR product was subsequently subjected to a real-time PCR assay targeting the HIV-1 R/U5 DNA region. This second PCR step allows for quantification of the amount of integrated viral DNA. The sum of these two PCRs is herein called integrated viral DNA. It is important to state that because the second round of PCR uses HIV-1-specific primers, it is necessary to control this experiment by conducting PCR on samples that have not undergone the first round because retro-transcribed DNA would be amplified by the second PCR. Samples that underwent only the second PCR are herein referred to as "reverse-transcribed viral DNA." High quantities of integrated HIV-1 DNA copies were detected in polarized trophoblasts upon infection with wild-type NL4-3 virions (Table  I) . Importantly, the number of viral DNA copies obtained upon infection with NL4-3 was severely reduced upon treatment with AZT (i.e., 66%), agreeing with the notion of true HIV-1 infection in these cells. We next tested viral integration using PBMCs and Jurkat cells. High quantities of integrated HIV-1 DNA copies were also detected in both cell types, and as expected, such levels were diminished by AZT. Interestingly, the number of integrated HIV-1 DNA copies was 2 logs higher in PBMCs and Jurkat cells compared with polarized JAR cells. Access to the cytoplasm, reverse transcription (as controlled with AZT in LTR-reporter gene expression assay) and viral DNA integration are potent markers of true HIV-1 infection in CD4 ϩ T lymphocytes. Because all these events are also observed in trophoblasts following exposure to HIV-1 (this article and Ref. 27 ), it can be concluded that true virus infection has indeed occurred in these cells.
Blocking the function of the endosomes inhibits HIV-1 infection
We have recently shown that the contact between HIV-1 and trophoblasts results in massive and rapid uptake of virions within cells by endocytosis (27) . Importantly, blocking the function of endosomes in these cells inhibits infection with the R5-tropic strain Ada-M, suggesting that events associated with HIV-1 infection in these cells are endocytic in nature (33) . In the present work, we extended this notion and studied infection with an X4-tropic variant in the presence of two classes of endosome inhibitors, i.e., the inhibitor of vacuolar proton ATPase bafilomycin A1 and the lysosomotropic weak base NH 4 Cl. Both drugs block vesicle acidification as well as endosomal and lysosomal degradation systems (51, 52) . Because, we have shown that HIV-1 infection of trophoblasts occurs independently of the viral Env proteins gp120 and gp41 (G. Vidricaire and M. J. Tremblay, submitted for publication), Env-deficient HIV-1 particles were also tested in this study. Polarized JAR cells were inoculated with singlecycle reporter viruses pseudotyped with Ada-M and HXB-2 (X4-tropic) Env or with Env-deficient reporter viruses (NL4-3⌬Env). Of note, a physiological concentration of TNF-␣ is added in all our infection studies because its presence is important for inducing LTR-driven gene expression in trophoblasts and as such was used in these assays (27) . When cells were pretreated with bafilomycin A1, virus gene expression was virtually lost for all virus preparations tested ( Fig. 2A) . In regard to NH 4 Cl, although the effect was strong it was slightly less potent than bafilomycin A1 (Fig. 2B) . Collectively, these data indicate that R5-and X4-tropic viruses are equally susceptible to the endosome inhibitors tested. Moreover, the process is independent of Env because infection with NL4-3⌬Env viruses was also inhibited by bafilomycin A1. Because scientists have relied extensively on endosome inhibitors such as bafilomycin A1 and NH 4 Cl to differentiate between pH-dependent (e.g., influenza virus and Semliki Forest virus) and pHindependent viral entry (reviewed in Ref. 53) , it can be concluded that HIV-1 infection of trophoblasts is pH dependent. 
Endosome inhibitors act at an early stage of HIV-1 replication
To determine the kinetics of HIV-1 travel inside the endosomal machinery and of its eventual escape from acidic endosomal compartments, the time required for HIV-1 to become resistant to inhibition by bafilomycin A1 or NH 4 Cl was determined. Polarized JAR cells were exposed to the studied drugs either before virus infection or at various time points following it. In this experimental setting, viral particles were added to the cells for 6 h at 37°C in the absence of inhibitors to allow viral infection to proceed. At this time point, infected cells were washed and treated with TNF-␣ to promote viral gene expression. The endosome inhibitors were added 6, 12, or 24 h after the onset of HIV-1 infection. As a control, the cells were pretreated for 30 min with bafilomycin A1 or NH 4 Cl before infection. The determination of the time points for adding the inhibitors to the cells was based on the following criteria. First, for productive infection to be seen, polarized JAR cells need to be in contact with HIV-1 for 6 h (our unpublished observations). Second, adding the endosome inhibitors before infection and then only 6 h postinfection (i.e., once viral particles have been washed off the cells) allows differentiating the effect of the drugs on HIV-1 life cycle without impacting the process of HIV-1 uptake. Treating polarized JAR cells with bafilomycin A1 30 min before virus infection yielded a 99% inhibition in viral gene expression for Ada-M and HXB-2 pseudotypes and a 94% reduction for Env-deficient viruses (Fig. 2C) , which is in agreement with the results presented in Fig. 2, A and B . However, when bafilomycin A1 was added 6, 12, or 24 h after initiation of virus infection, the effect of the drug was gradually lost. Similar observations were made with NH 4 Cl (Fig. 2D ), although this drug was initially less potent than bafilomycin A1. Therefore, it would appear that both drugs act within the first 6 h of virus infection. Hence, the requirement for low pH is associated with early events of the HIV-1 life cycle. Interestingly, this timing coincides with the presence of HIV-1 within the endosomal machinery (27, 33) .
Endosome inhibitors vs HIV-1 internalization
We next verified whether the drugs had an impact on virus internalization. JAR cells were pretreated with bafilomycin A1 or NH 4 Cl and then briefly exposed to pseudotyped or Env-deficient viruses (i.e., 1 h) before an acid treatment to remove uninternalized viruses. The level of the viral core protein p24 in the cell lysates was quantified through the use of an enzymatic assay. Bafilomycin A1 induced a 31, 43, and 55% reduction in internalization of Ada-M, HXB-2, and NL4-3⌬Env viruses, respectively (Fig. 3A) . Bafilomycin A1 blocks not only vesicle acidification but also organelle movements from early to late endosomes (52) . In the presence of bafilomycin A1, internalized molecules cannot proceed beyond early endosomes and are thus returned to the extracellular milieu. In such conditions, it is quite conceivable that bafilomycin A1 triggers in part the recycling of HIV-1 to the apical pole, thus creating the impression of reduced viral entry. Bafilomycin A1 was also tested on HIV-1 binding to trophoblasts at 4°C and did not modulate this event (data not shown). On the opposite, comparable amounts of internalized viruses were found in cells treated or not with NH 4 Cl and this for the three virus preparations tested (Fig. 3B) .
Endosome inhibitors induce a diminution in HIV-1 p24 cytosolic release
Although a reduction in virus uptake is seen with bafilomycin A, it is unlikely to be the sole reason for the marked decrease in HIV-1 infection observed in polarized trophoblasts. Indeed, NH 4 Cl, which also blocks infection, did not reduce significantly viral uptake. We next sought to define how blocking the endosome translates into a reduction of HIV-1 infection. Because HIV-1 needs to access the cytoplasm for infection to ensue, cytosolic release of the viral nucleocapsid p24 is believed to be an indicator of productive infection (34) . Consequently, drugs causing a reduction in cytosolic release of p24 might be associated with reduced infection resulting from diminished endosomal escape. In other words, we verified whether blocking the function of the endosomes translates into diminished cytoplasmic release of viral material. First, in a control experiment, polarized JAR cells were exposed to HXB-2 pseudotypes for either 30 min or 2 h. The infected cells were then trypsinized, washed, and the amount of viruses present in the cytosolic and vesicular fractions was measured. We found that at 30 min postinfection, the viral material was exclusively located within the vesicular fraction of the cells, whereas at 2 h postinfection, 20% of the internalized viral particles had already reached the cytoplasm (Fig. 3C ). These data are fully in agreement with a previous report published by this laboratory on JAR cells using this same technique (27) and underscore two important notions. First, the technical procedure used in this study for separating cytosolic and vesicular fractions is valid because it does not result in cross-contamination of either fraction. Second, they illustrate clearly the endocytic nature of HIV-1 uptake in polarized JAR cells. A second series of controls were also performed. It is well established that entry of VSV occurs by receptor-mediated endocytosis. Subsequently, during its itinerary through the endosomal compartments, the VSV-G protein acquires a low pH-induced fusion-competent form, allowing for fusion of the viral membrane with endosomal and lysosomal membranes (54) . Based on this notion, polarized JAR cells were pretreated or not with bafilomycin A1 or NH 4 Cl and then exposed for 2 h to NL4-3⌬Env viruses pseudotyped with the VSV-G envelope, and fractionation assays were conducted. Although VSV-G is internalized by endocytosis, we found that VSV-G viral particles were predominantly located within the cytosolic fraction of polarized JAR cells. This indicates that VSV-G efficiently reaches the cytoplasm upon internalization in trophoblasts in such a way that the duration of its presence within the endosomes is short. These data are in agreement with a previous report (G. Vidricaire and M. J. Tremblay, submitted for publication) and with the fact that VSV-G is highly infectious in polarized JARs. However, upon treatment with bafilomycin A1, no viral particles could escape the endosomes because all viral particles were located within the vesicular fraction (Fig. 3D ). This shows both the validity of the fractionation procedure and the potency of the drug. Although NH 4 Cl reduced the cytoplasmic presence of VSV-G pseudotypes from 83 to 56%, the effect was less potent than that of bafilomycin A1. Hence, we may conclude that NH 4 Cl is not as efficient as bafilomycin A1 for blocking the cytoplasmic release. Next, fractionation assays were performed in polarized JAR cells that were pretreated with bafilomycin A1 or NH 4 Cl and then exposed to Ada-M and HXB-2 pseudotyped viruses. The presence of bafilomycin A1 resulted in a diminution of HIV-1 within the cytoplasm. Indeed, a shift from 36 to 23% ( p Ͻ 0.01) of p24 present in the cytoplasm was seen for Ada-M, and a shift from 45 to 17% ( p Ͻ 0.01) was observed for HXB-2 (Fig. 3, E and F, respectively) . NH 4 Cl did not significantly alter the cytosolic release of Ada-M or HXB-2. Given that NH 4 Cl only partly modulated the cellular distribution of VSV-G pseudotypes, it is not surprising that it did not modulate the cellular distribution of HIV-1. We may conclude that bafilomycin A1, by blocking the function of the endosomes, inhibits HIV-1 infection of polarized JAR cells. The mechanism may be in part associated with a reduced access to the cytoplasm.
Rab5 regulates HIV-1 infection
In the next series of experiments, the role played by specific Rab proteins in HIV-1 infection of polarized trophoblasts was studied. The primary objective of these experiments was to define the endocytic compartment(s) involved in the process of HIV-1 infection in this cell type. We recently provided evidence that HIV-1 is internalized in trophoblasts via a clathrin/caveolae-independent endocytic pathway that is sensitive to cholesterol-disrupting drugs (G. Vidricaire and M. J. Tremblay, submitted for publication). Interestingly, additional results show that although HIV-1 is initially FIGURE 3. Virus internalization and cytosolic delivery are reduced by bafilomycin A1. Polarized JAR cells were first pretreated or not with bafilomycin A1 (A) or NH 4 Cl (B). The cells were then exposed to pseudotyped and Env-deficient viruses for 1 h at 37°C. Viral entry was assessed by evaluating the amount of p24 in each cell lysate. Data shown are expressed as the means Ϯ SD of triplicate samples and are representative of three independent experiments. For fractionation assays, polarized JAR cells were pretreated or not with bafilomycin A1 or NH 4 Cl and then exposed to HXB-2 (C and F), VSV-G (D), and Ada-M (E) pseudotypes. The cells were disrupted by Dounce homogenization, and levels of p24 were evaluated in each cellular fraction. Data shown are expressed as the means Ϯ SD of the ratio of p24 present in the cytosol or vesicles over the sum of p24 present in the two fractions. Data shown are representative of three independent experiments. Asterisks denote statistically significant data ‫,ءء(‬ p Ͻ 0.01). Statistical analysis was achieved using the Student paired t test, with a two-tailed distribution. Homogeneity of variances was also tested and deemed as such in each case. localized in transferrin-negative organelles, internalized viral particles will eventually transit to transferrin-positive endosomes, suggesting a merger between nonclassical and classical endocytic pathways in trophoblasts (33) . To define the relationship between the presence of HIV-1 within early endosomes and the infection of polarized trophoblasts, we investigated the role played by the small GTPase Rab5, which regulates the biogenesis of these endosomes. Polarized JAR cells were transiently transfected with expression vectors coding for wild-type, dominant-active, and dominant-inactive Rab5. Substitution of glutamine to leucine at aa 79 (Rab5 Q79L) results in a Rab5 protein that cannot hydrolyze GTP, leaving it in an active state. In contrast, mutation of the serine to an asparagine at position 34 (Rab5 S34N) causes the protein to have an affinity for GDP that is 100-fold greater than that of GTP, therefore maintaining the protein in an inactive state. As controls, the cells were either mock-transfected or transfected with the EGFP expression vector. Contrary to the dominant-negative Rab5 (i.e., Rab5 S34N), the Rab5 WT and Rab5 Q79L molecular constructs tested produced a potent but incomplete inhibition of infection with Ada-M pseudotypes in polarized trophoblasts that ranged from 50 to 76% (Fig. 4A ). The effect observed was proportional to the amount of DNA used for transfection and held true for the two others virus preparations tested (Fig. 4, B and C) . In contrast, HIV-1 particles pseudotyped with VSV-G Env were weakly affected by the expression of the Rab5 proteins (Fig. 4D ). We may conclude that the effects observed by expression of the Rab5 mutants in trophoblasts are 1) specific to HIV-1, 2) related to early events in HIV-1 replication, and 3) not related to downstream events affecting HIV-1 LTR-driven gene expression. Hence, by blocking access to early endosomes with dominant-negative Rab5 or conversely by preventing movements beyond early endosomes with wild-type or dominant-active Rab5, virus infection is reduced in polarized JAR cells. The effect cannot be due to decreased HIV-1 internalization because similar amounts of viral particles are found in polarized JAR cells expressing these Rab5 mutants (see below).
Viral uptake and cytosolic p24 release are not affected by wortmannin
Previous work has shown that inhibition of PI3K with wortmannin leads to the release of EEA1 from early endosomes, which reduces early endosome fusion (55) . To better define the requirement for HIV-1 to transit via Rab5 ϩ organelles, the subsequent experiments were performed with the PI3K inhibitor wortmannin. Although wortmannin slightly increased Ada-M uptake in polarized JAR cells, internalization of HXB-2 pseudotypes was not affected by wortmannin (Fig. 5A ). This is in agreement with the fact that internalization of HIV-1 does not proceed via the classical endocytic pathway in trophoblasts (G. Vidricaire and M. J. Tremblay, submitted for publication). PI3K-dependent signaling pathway also controls receptor sorting out of early endosomes but not membrane transport (55) . Keeping this in mind, the effect of wortmannin was tested on cytosolic release of the viral nucleocapsid p24 in polarized JAR cells. Wortmannin did not modulate in a statistically significant manner the cellular distribution of pseudotyped viruses in polarized trophoblasts (Fig. 5B) . Thus, it can be proposed that HIV-1 cytoplasmic access from the endosomal machinery is most likely independent of PI3K activity. In agreement with these results, wortmannin did not modulate HIV-1 infection of trophoblasts (data not shown).
Arf6 does not modulate HIV-1 infection
Some transmembrane proteins internalized by a clathrin-and lipidraft-independent mechanism return to the plasma membrane in an Arf6-dependent manner (Ras-related small GTP protein). Alternatively, they can fuse with the classical early endosomes and traffic to late endosomes/lysosomes upon inactivation of Arf6. Expression of a constitutively active Arf6 mutant (Arf6 Q67L) prevents molecules internalized in this clathrin/lipid raft-independent pathway to fuse with clathrin cargo-containing endosomes and their subsequent routing to late endosomes. By contrast, exogenous expression of wild-type Arf6 has no discernible effect on cells (43) . Transient transfection of polarized JAR cells with wild-type Arf6, dominant-active Arf6 Q67L, and dominant-negative Arf6 T27N had no discernible effect on infection with HIV-1 pseudotyped with Ada-M, HXB-2, or VSV-G Env (Fig. 6 ). Therefore, HIV-1 is unlikely to transit via Arf6-expressing endosomes in trophoblasts.
Rab7 regulates HIV-1 infection
HIV-1 migrates and accumulates inside late endosomes within the first hours of internalization into polarized trophoblasts (33) . To determine whether there is a correlation in polarized JAR cells between the presence of HIV-1 within these organelles and the process of infection, the effect of Rab7 was tested. The small GT-Pase Rab7 controls movements of vesicles from early to late endosomes and the formation of lysosomes. Polarized JAR cells were transiently transfected with dominant-negative and dominant-active Rab7 expression vectors. The two Rab7 proteins tested resulted in an almost complete blockade of HIV-1 gene expression in trophoblasts. Indeed, up to 88% inhibition in viral expression was observed (Fig. 7) . The effect observed was proportional to the amount of DNA used for transfection and held true for all three strains of HIV-1 tested. In contrast, HIV-1 particles pseudotyped with the VSV-G envelope were minimally affected by the expression of the Rab7 proteins (Fig. 7D) . Hence, when blocking access to late endosomes with dominant-negative Rab7 or conversely by promoting movements to lysosomes with wild-type or dominantactive Rab7, HIV-1 infection is inhibited in polarized JAR cells. The effect cannot be due to decreased HIV-1 internalization because comparable amounts of viral particles are found in polarized JAR cells expressing these Rab7 mutants (Fig. 8 ). Similar data on viral uptake were obtained when testing the Rab5 expression vectors.
HIV-1 infection is independent of Rab11
Having shown in a previous study that a small proportion of internalized HIV-1 reaches Rab11-expressing recycling organelles upon uptake into polarized trophoblastic cells (33), the possible modulatory effect of different Rab11 constructs on HIV-1 infection was tested (i.e., Rab11 WT, dominant-negative Rab11 S25N, and dominant-active Rab11 Q70L). None of the Rab11 expression vectors tested had an effect on HIV-1 infection of polarized JAR cells with reporter viruses (data not shown), thus suggesting that virus infection of placental cells does not require a transit through these organelles.
Discussion
The placenta is thought to play a central role during in utero HIV-1 transmission. However, the molecular events associated with HIV-1 infection of placental cells are still a mystery. In the present study, we investigated the role played by specific Rab proteins, known to dictate the vesicular transport between the various endocytic compartments, in the process of HIV-1 infection of polarized human placental cells. The rationale of this study being that HIV-1 circulates through multiple organelles upon internalization into trophoblasts, and the presence of HIV-1 within the endosomes FIGURE 5. Viral internalization and p24 cytosolic release are not affected by wortmannin. Polarized JAR cells were pretreated or not with wortmannin and then exposed to Ada-M or HXB-2 pseudotyped viruses for 1 h (A). Viral entry was measured by evaluating the amount of p24 in each cell lysate. Data shown are expressed as the means Ϯ SD of triplicate samples and are representative of three independent experiments. For fractionation assays, polarized JAR cells were pretreated or not with wortmannin and then exposed to Ada-M or HXB-2 pseudotyped viruses for 4 h (B). The cells were disrupted by Dounce homogenization, and levels of p24 were evaluated in each cellular fraction. Data shown are expressed as the means Ϯ SD of the ratio of p24 present in the cytosol or vesicles over the sum of p24 present in the two fractions. Data shown are representative of three independent experiments.
is a required step for infection to proceed in these cells. How both events are interconnected is still unknown. We found an unprecedented relationship between placental infection and the presence of HIV-1 within endosomes. It is known that both HIV-1 fusion and endocytosis can occur simultaneously in CD4 ϩ T lymphocytes but with sharply different functional consequences. Indeed, in this particular cell type, fusion promotes productive infection whereas endocytosis leads to viral degradation. Given that endosome inhibitors increase HIV-1 infectivity in CD4 ϩ T cells and in an epithelial cell line (i.e., MAGI), it was proposed that fusion within the endosomes is a possible process when viral particles are spared from degradation (56, 57) . We found that the mechanism associated with HIV-1 infection of polarized trophoblasts is utterly different. For all HIV-1 strains tested, viral replication was not increased but rather virtually lost when endosome inhibitors were added within the first moments of infection. However, the endosome inhibitors did not reduce infection when added at a later time point following exposure to HIV-1, most likely because a fraction of the virus had proceeded beyond the low pH-sensitive step. We conclude that the initial presence of HIV-1 within the endosomes in trophoblasts is mandatory for the subsequent steps leading to infection. HIV-1 infection of trophoblasts, unlike CD4 ϩ T cells, is thus endocytic in nature. Endocytosis of the retrovirus as a mechanism required for infection of a target cell is rare and poorly characterized. Inhibition of macropinocytosis in macrophages leads to reduced viral infection. Although, most virions are subsequently degraded, fusion leading to capsid release in the cytosol is postulated to take place inside ves-icles. Infection of macrophages is weakly affected by treatment with bafilomycin A1 (58) . Human mannose receptor-mediated HIV-1 infection of astrocytes was inhibited by bafilomycin A and NH 4 Cl, thus suggesting that infection in these cells also results from HIV-1 endocytosis (59) .
The key question we asked in this article is how the presence of HIV-1 within the endocytic compartments relates to infection. Among other events, Rab5 regulates clathrin-mediated endocytosis and fusion of coated pits with early endosomes (36) . We found that Rab5 did not modulate viral uptake into polarized trophoblasts. This agrees with our earlier observation that internalization of HIV-1 in these cells is independent of clathrin-coated pits (G. Vidricaire and M. J. Tremblay, submitted for publication). However, we observed that the dominant-negative Rab5 mutant, which blocks fusion of incoming vesicles to early endosomes, inhibited HIV-1 infection in trophoblasts. Hence, Rab5-dependent transport to early endosomes is a necessary step for HIV-1 infection in these cells. Remarkably, these observations also imply that HIV-1-containing endocytic vesicles derived from a Rab5-independent process are able to fuse with early endosomes that are presumably Rab5 positive. Indeed, HIV-1 transits from the nonclassical to the classical pathway following uptake by trophoblasts via a clathrin/ caveolae-independent pathway (G. Vidricaire and M. J. Tremblay, submitted for publication). This constitutes an unusual and poorly characterized event; one elegant example includes caveolar vesicles moving from caveosomes to early endosomes in a Rab5-dependent manner (35) . Of note, the reason why Ada-M pseudotypes were not affected by the dominant-negative Rab5 vector is intriguing. Given that the difference between Ada-M and HXB-2 relates to Env and that infection of trophoblasts is Env independent, this point is difficult to interpret. It is possible that posttranslation modifications of Env (e.g., glycosylation pattern) differ between Ada-M and HXB-2. These differences, although not impacting on the early steps in HIV-1 life cycle, might modulate the fate of the viral material within endocytic compartments. We also found that wild-type and constitutively active Rab5 proteins inhibited HIV-1 infection. Dominant-active Rab5 Q79L causes the accumulation within endosomes of lysosomal proteins that normally cross the endosome compartments before reaching lysosomes (60) . Likewise, small and large dextran molecules remain colocalized after endocytosis in Rab5 Q79L-expressing cells, and their separation into distinct endocytic organelles is delayed severely (61) . Hence, by causing entrapment of HIV-1 within early endosomes, Rab5 Q79L or Rab5 WT was detrimental to HIV-1 infection in trophoblasts. We conclude that although reaching early endosomes is required for the biology of HIV-1 within trophoblasts, this step is not sufficient per se for infection to take place.
Importantly, we found that HIV-1 infection was virtually lost upon expression of a dominant-negative Rab7 mutant, which blocks the transport to late endosomes and results in retention in Rab5-positive early endosomes. Because dominant-active Rab5 and dominant-negative Rab7, which both prevent access to late endosomes, inhibited infection, we can conclude that HIV-1 trafficking to late endosomes is a mandatory step for infection to proceed in trophoblasts. This also implies that infection is related to events not occurring within early endosomes but rather within late endosomes. In this context, the role of Rab5 is to promote HIV-1 transit to early endosomes, a step known to be important for subsequently reaching late endosomes via Rab7. Of note, expression of Rab5 expression vectors in polarized trophoblasts reduced HIV-1 infectivity by 50 to 76%, whereas the observed Rab7-mediated inhibition was much more dramatic. Transfection efficiencies obtained in this study (i.e., 50%) parallel the inhibition achieved by the Rab5 expression vectors and as such may explain the extent of inhibition obtained with these vectors. This being said, this argument is difficult to make because it would imply that a direct correlation exists between transfection efficiency, viral uptake, and infection in trophoblasts. However, a direct association between viral uptake and infection is unlikely to be the case in these cells. Indeed, even though virtually 100% of polarized JAR cells internalize HIV-1 viral particles (33), infection rates are expected to be much lower in these cells. This is based on the idea that a maximum of 10% of CD4 ϩ T cells are infected by HIV-1 both in vivo and in vitro (our unpublished observations and Ref. 62 ) and that trophoblasts are recognized to be even less susceptible to HIV-1 infection. In other words, all trophoblastic cells internalize HIV-1 but only a subset of them becomes infected. Hence, our data raise the alternative and intriguing possibility that HIV-1 particles reach late endosomes not solely via Rab5-positive early endosomes but possibly via yet to be defined Rab5-negative early endosomes as well.
In contrast, we provide evidence that infection is unlikely to be associated with a transit via Arf6-or Rab11-containing organelles given that Arf6 and Rab11 mutants did not modulate HIV-1 infection in polarized trophoblasts. It has been demonstrated previously that the bulk transport from early to late endosomes is not affected after inhibition of the PI3K pathway by wortmannin but that the sorting of down-regulated receptor molecules out of early endosomes is inhibited (55) . In apparent contradiction with a mandatory transit to late endosomes for HIV-1, we observed that wortmannin failed to inhibit HIV-1 cytoplasmic access in polarized trophoblasts. Consequently, HIV-1 particles reach late endosomes in a process resembling bulk transport and as such do not require PI3K. This is supported by our earlier finding that uptake of HIV-1 in trophoblasts occurs via numerous and rather nonspecific viruscell interactions (G. Vidricaire and M. J. Tremblay, submitted for publication).
It is important to point that our data also illustrate the existence of a delicate balance between the organelles. Indeed, if movements from late endosomes toward lysosomes are favored upon expression of dominant-active Rab7, HIV-1 infection is inhibited. This may be due to increased viral degradation within lysosomes based on the idea that Rab7 Q67L increases perinuclear aggregation and fusion of lysosomes. It is surprising that infection by HIV-1 pseudotyped with VSV-G was poorly modulated by a dominantnegative Rab5 mutant as described previously (63) . The difference in cell lines may account for such a discrepancy. It is unlikely to be due to VSV-G infection rates that may not be overcome by the levels of expression achieved by Rab expression vectors. Indeed, when performing these experiments with a titer of VSV-G pseudotypes giving more comparable luciferase readouts to HIV-1 pseudotypes, VSV-G remained unaffected (data not shown).
Internalization of viruses within a given target cell is in itself generally not sufficient per se for productive infection because incoming viruses are still part of the extracellular space once located within endosomes. The acidification of endocytic vesicles triggers a conformational change in the viral Env protein of enveloped viruses causing fusion of the virus with the endocytic inner membrane and the release of viral genome at appropriate locations (reviewed in Ref. 64) . In contrast, naked viruses are released upon rupture of the cargo endocytic vesicles; alternatively, they generate a pore through which the genome can enter the cytosol (reviewed in Refs. 64 and 65). In trophoblastic cells, the cytosolic p24 content decreased in the presence of bafilomycin A1, suggesting that when endosomal function is blocked, the mechanism whereby viral particles present in vesicles are released into the cytosol is inhibited and as such infection is lost. Hence, these data support the notion that HIV-1 infection in polarized trophoblasts is associated with a pH-dependent endosomal escape. If a strict correlation between the presence of viral material within the cytoplasm and infection exists in trophoblasts as it is the case in CD4 ϩ T cells, it is intriguing that the cytosolic p24 content was reduced and not blocked by bafilomycin A1 and was not affected by NH 4 Cl. Controls were performed to ensure that the technical procedure to separate cytosolic and vesicular fractions was proper; hence, it is unlikely due to cross-contamination between the fractions. In contrast, the fact that the cytosolic release of VSV-G was completely blocked by bafilomycin A1 but only partly inhibited by NH 4 Cl indicates that bafilomycin A1 was more potent in this assay than NH 4 Cl and explains why only bafilomycin A1 modulated the cytoplasmic release of HIV-1. Hence, we believe that an incomplete blockade in cytoplasmic access triggered by the drugs used is related to the nature of the assay. This being said, both drugs blocked viral infection within the first 6 h of infection, implying that they abrogate steps within the early events of HIV-1 infectious cycle. Therefore, we cannot exclude that these drugs also affect some events leading to viral integration that occur beyond endosomal escape. Additional experiments are warranted to resolve this issue.
Among other events, low endosomal pH regulates activation of lysosomal hydrolases and viral Env protein conformational changes needed for intraendosomal fusion. No reduction in HIV-1 LTR-directed reporter gene expression was seen upon addition of leupeptin (lysosomal protease inhibitor) to polarized trophoblasts infected with pseudotyped or Env-deficient viruses (data not shown). Therefore, HIV-1 must escape the endosomes and reach the cytoplasm through a different mechanism. In contrast, we found that endosome inhibitors blocked infection of polarized trophoblasts with wild-type and Env-deficient viruses. Therefore, we can conclude that HIV-1 endosomal escape in trophoblasts does not occur by leakage upon the action of cellular hydrolase and is independent of the Env proteins. Pivotal information is now to be considered. First, HIV-1 is primarily located within late endosomes upon internalization in trophoblasts (33) . Second, inhibiting access to late endosomes through dominant-negative Rab7 blocks HIV-1 infection. Third, HIV-1 bears a lipid membrane and hostderived cell membrane proteins acquired upon budding (66) . Consequently, HIV-1 intraendosomal fusion is expected to take place. This process most likely parallels recycling of molecules targeted to the inner vesicles of late endosomes. Indeed, fusion between the exoplasmic leaflets of the late endosome and inner vesicles, i.e., back-fusion, is thought to mediate recycling from inner vesicles (67, 68) . The intracellular machinery that controls such an event has yet to be defined, but HIV-1 as an enveloped virus among inner vesicles within the endosomes is likely to use such a strategy. Interestingly, low endosomal pH promotes back-fusion.
Our current working model proposes that, upon internalization by a clathrin/caveolae-independent pathway in polarized trophoblasts, HIV-1 reaches regions enriched in lipid rafts. From this location, the internalized viral particles transit to Rab5-expressing early endosomes. This movement is required for subsequently reaching late endosomes via Rab7. We propose that infection is related to events occurring within late endosomes because HIV-1 infection is lost when access to late endosomes is blocked by expression of Rab5 mutants or dominant-negative Rab7. This is further supported by the fact that HIV-1 infection was inhibited by bafilomycin A1, which not only neutralizes endosomal pH but also blocks early to late organelle movements. In addition, HIV-1 accumulates within CD63-positive organelles within 4 h of viral uptake (33) . In contrast, when movements from late endosomes to lysosomes are favored by dominant-active Rab7, infection is inhibited presumably because increased degradation of viral particles is taking place. Our data are in support of endosomal escape occurring upon intraendosomal HIV-1 back-fusion. The process is independent of the viral Env proteins gp120 and gp41 but requires an acidic environment (i.e., low pH).
In summary, this study provides an unprecedented understanding of the intracellular route taken by HIV-1 within human placental cells. The results presented herein are highly significant. First, the mechanism underscored in this work has never been described for HIV-1. Second, the human polarized trophoblast barrier is considered as a primary target for maternal blood-borne HIV-1 infection. Third, the results obtained can also enhance our understanding of the biology of HIV-1 in adults. Indeed, epithelial cells are the portal of entry for HIV-1 during primary infection in adults, and viral internalization is associated with endocytosis in these cells. Moreover, endocytosis may be important for macrophages and dendritic cells, which are cell types playing key roles in the pathogenesis of HIV-1 infection. Furthermore, the findings presented in this article raise concerns in terms of treatment strategy. Administration of clinically approved drugs such as amantadine or chloroquine has been postulated to increase HIV-1 infectivity by sparing viruses from degradation in late endosomes and lysosomes (56, 57) . Based on the present data, it can be proposed that an opposite effect would be seen with these drugs with respect to vertical transmission of HIV-1. In contrast, our data raise the interesting possibility that altering the endocytic Rab content by intervention in appropriate signal transduction events may offer a new strategy for modulating the targeting of HIV-1 to a degradative compartment (69) . Additional studies are needed to define the validity of this approach.
